Vertex Pharmaceuticals

Mentioned in 6 analyzed podcast episodes across 6 shows

Mentioned On

Motley Fool Money The Top Line BioSpace Biotech Hangout Pharma and BioTech Daily Founder's Story

Episode Mentions

Motley Fool Money · Jul 10, 2026

What History Teaches Us About Today’s Market

“Mentioned as biopharma hidden gems opportunity with proprietary platform and growth potential”

AI Infrastructure Investment and Capital RequirementsEnterprise vs. Consumer Technology Adoption PatternsNVIDIA Competitive Positioning and Robotics Opportunity

View Analysis

The Top Line · Jul 10, 2026

A $10B deal, China trial scrutiny and highlights from ADA 2026

“Announced $10B acquisition of Crinetics to expand into rare endocrine diseases with approved drug Pelsonify”

Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes

View Analysis

BioSpace · May 13, 2026

Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay

“CEO Reshma Kowal-Rahmani dropped in compensation rankings after swapping places with GSK's Walmsley”

FDA Commissioner leadership transition and removalRegulatory uncertainty and HHS agency turnoverCommissioner's National Priority Review voucher program

View Analysis

Biotech Hangout · May 8, 2026

Episode 182 - May 8, 2026

“Large-cap biotech with pipeline events driving investor interest over commercial business strength”

Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns

View Analysis

Pharma and BioTech Daily · May 6, 2026

Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily

“Encountered tolerability issues with inhaled cystic fibrosis candidate developed with Moderna”

AI Center of Excellence and Digital Transformation in Drug DevelopmentFDA Approval Processes and Regulatory ModernizationCAR-T Cell Therapy Expansion Beyond Oncology

View Analysis

Founder's Story · Feb 27, 2026

The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA

“Advanced R&D company in cell therapy that partnered with TreeFrog Therapeutics for cell encapsulation technology development”

Tech Bio Definition and ApplicationsPersonalized Medicine and Single-Vial-Per-Patient TherapiesCell and Gene Therapy Manufacturing

View Analysis